EcoDrugPlus

Neuropeptide Y Receptor Y5

Ensembl ID : ENSPEMG00000021268
Gene Symbol: NPY5R
1 Cross references
135 Possible Orthologues:

Neuropeptide Y Receptor Type 4

Ensembl ID : ENSPEMG00000028618
Gene Symbol: LOC102906184
3 Cross references
116 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSPEMG00000019912
Gene Symbol: NTSR1
3 Cross references
211 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSPEMG00000002759
Gene Symbol: NTRK1
3 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSPEMG00000000060
Gene Symbol: NTRK2
3 Cross references
286 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSPEMG00000010258
Gene Symbol: NTRK3
3 Cross references
269 Possible Orthologues:

Neutrophil Elastase

Ensembl ID : ENSPEMG00000016090
Gene Symbol: LOC102907326
3 Cross references
102 Possible Orthologues:

Nicastrin

Ensembl ID : ENSPEMG00000012185
Gene Symbol: NCSTN
3 Cross references
203 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSPEMG00000021513
Gene Symbol: NAMPT
1 Cross references
235 Possible Orthologues:

Nischarin

Ensembl ID : ENSPEMG00000003312
Gene Symbol: NISCH
3 Cross references
209 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSPEMG00000004104
Gene Symbol: NOS2
3 Cross references
163 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSPEMG00000013515
Gene Symbol: NOTCH1
3 Cross references
273 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).